Cargando…
New mechanisms of antiplatelet activity of nifedipine, an L-type calcium channel blocker
Platelet hyperactivity often occursd in hypertensive patients and is a key factor in the development of cardiovascular diseases including thrombosis and atherosclerosis. Nifedipine, an L-type calcium channel blocker, is widely used for hypertension and coronary heart disease therapy. In addition, ni...
Autor principal: | Chou, Tz-Chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
China Medical University
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265014/ https://www.ncbi.nlm.nih.gov/pubmed/25520937 http://dx.doi.org/10.7603/s40681-014-0024-z |
Ejemplares similares
-
Antiplatelet Effect of Clopidogrel Can Be Reduced by Calcium-Channel Blockers
por: Seo, Kwon-Duk, et al.
Publicado: (2014) -
Calcium channel blockers reduce the antiplatelet effect of clopidogrel
por: Siller-Matula, Jolanta M, et al.
Publicado: (2008) -
Mechanisms of Nifedipine-Downregulated CD40L/sCD40L Signaling in Collagen Stimulated Human Platelets
por: Chen, Tso-Hsiao, et al.
Publicado: (2015) -
The L-type Ca(2+) Channel Blocker Nifedipine Inhibits Mycelial Growth, Sporulation, and Virulence of Phytophthora capsici
por: Liu, Peiqing, et al.
Publicado: (2016) -
The L-type Ca(2+) Channels Blocker Nifedipine Represses Mesodermal Fate Determination in Murine Embryonic Stem Cells
por: Nguemo, Filomain, et al.
Publicado: (2013)